Supporting AstraZeneca's Bold Ambition: Scaling Advanced Therapies for Success | PMWS25 Keynote

In this PMWS session, Sheena Behn, Vice President of Vaccine & Immune Therapies Supply Chain and Vice President for Oncology Supply at AstraZeneca, explores how the company is scaling manufacturing and supply chain capabilities to support its ambitious goal of delivering 20 new medicines by the end of the decade. As advanced therapies and next-generation treatment modalities continue to transform healthcare, pharmaceutical manufacturers face new challenges in scaling production while maintaining quality, speed, and reliability. Behn discusses how AstraZeneca is adopting innovative manufacturing strategies to unlock the potential of advanced therapies and meet growing global demand for targeted medicines. The session examines the role of smart factories, flexible manufacturing networks, modular facility designs, and continuous manufacturing technologies in accelerating supply and improving responsiveness. Attendees will also gain insight into the operational challenges associated with emerging therapeutic modalities and how AstraZeneca is building resilient supply chains capable of supporting future growth. In addition, Behn highlights the company's commitment to sustainable manufacturing practices, including energy-efficient operations and initiatives designed to reduce environmental impact while expanding production capacity. Key topics include: Scaling advanced therapies and next-generation pharmaceutical manufacturing AstraZeneca’s strategy to deliver 20 new medicines by 2030 Manufacturing and supply chain challenges for emerging therapeutic modalities Smart factories and digital transformation in pharmaceutical operations Flexible, modular, and continuous manufacturing approaches Building resilient and scalable pharmaceutical supply chains Accelerating speed-to-patient through manufacturing innovation Sustainable manufacturing and energy-efficient operations Future-ready manufacturing strategies for biologics, oncology, and advanced therapies About PMWS: The Pharma Manufacturing World Summit (PMWS) is a premier gathering of industry leaders, pharmaceutical manufacturing executives, and experts dedicated to exploring innovative strategies, emerging trends, and best practices in the evolving world of pharmaceutical manufacturing management. Through curated discussions and expert-led sessions, PMWS brings together manufacturing, quality, technical operations, and supply chain leaders to exchange insights, tackle industry challenges, and drive innovation across pharmaceutical production and operations. Learn more at https://www.executiveplatforms.com/pmws/